Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.

Abstract:

:Andrographolide (Andro), a natural compound isolated from Andrographis paniculata, has been demonstrated to have anticancer efficacy in several types of tumors. In the present study, the anticancer effects and mechanism of Andro in human malignant melanoma were investigated. Cell viability analysis was performed using an MTT assay and the effect of Andro on the cell cycle and apoptosis of human malignant melanoma cells was determined by flow cytometry. Western blot analysis was performed to evaluate the protein expression levels of human malignant melanoma cells following treatment with Andro. The results revealed that Andro potently inhibited cell proliferation by inducing G2/M cell-cycle arrest in human malignant melanoma C8161 and A375 cell lines. In addition, treatment with Andro induced apoptosis, which was associated with the cleavage of poly(adenosine diphosphate-ribose) polymerase and activation of caspase-3. It was observed that Andro induced activation of the c-Jun N-terminal kinase and p38 signaling pathway, which may be connected with cell cycle arrest and apoptosis. In conclusion, the results demonstrated that Andro may be a promising and effective agent for antitumor therapy against human malignant melanoma.

journal_name

Oncol Lett

journal_title

Oncology letters

authors

Liu G,Chu H

doi

10.3892/ol.2018.7941

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

5301-5305

issue

4

eissn

1792-1074

issn

1792-1082

pii

OL-0-0-7941

journal_volume

15

pub_type

杂志文章
  • Next generation sequencing-based analysis of mitochondrial DNA characteristics in plasma extracellular vesicles of patients with hepatocellular carcinoma.

    abstract::Emerging evidence has revealed that mitochondrial DNA (mtDNA) is encapsulated in plasma extracellular vesicles (EVs). However, the characteristics of mtDNA in EVs from patients with cancer remain largely unexplored, which greatly limits its clinical application. Whole genome and capture-based sequencing found that EV ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2020.11831

    authors: Li Y,Guo X,Guo S,Wang Y,Chen L,Liu Y,Jia M,An J,Tao K,Xing J

    更新日期:2020-09-01 00:00:00

  • Comprehensive clinical and pathological analysis of three rare vascular tumor cases.

    abstract::The histological boundary between benign and malignant vascular tumors is not clear. Thus, the discrepancies between clinical judgement and pathological diagnosis often lead to a difficult clinical decision, and may result in misdiagnosis. In order to develop more effective treatment methods, the clinical and patholog...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2012.1025

    authors: Li F,Ma L,Zhang L,Zheng L,Lv X,Fu J

    更新日期:2013-02-01 00:00:00

  • Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.

    abstract::In the present study, the effect of immunophenotyping on the prognoses of patients with multiple myeloma (MM) treated with bortezomib plus dexamethasone was investigated. The study involved 46 patients with MM, and analyzed the prognostic significance of the expression of cluster of differentiation (CD)45, CD56 and ma...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5920

    authors: Iriyama N,Miura K,Hatta Y,Kobayashi S,Uchino Y,Kurita D,Sakagami H,Takahashi H,Sakagami M,Kobayashi Y,Nakagawa M,Ohtake S,Iizuka Y,Takei M

    更新日期:2017-05-01 00:00:00

  • N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3.

    abstract::N-myc downstream-regulated gene 1 (NDRG1) is a multifunctional protein associated with carcinogenesis and tumor progression. The function of NDRG1 in hepatocellular carcinoma (HCC) cells remains controversial. The present study investigated the role of NDRG1 in HCC as well as its molecular mechanism using a range of t...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.5924

    authors: Song Y,Wu G,Zhang M,Kong Q,Du J,Zheng Y,Yue L,Cao L

    更新日期:2017-05-01 00:00:00

  • Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells.

    abstract::Lysine-specific demethylase 1 (LSD1) functions as a transcriptional coregulator by modulating histone methylation and has been associated with numerous high-risk cancers. Previously, our group and others identified LSD1 as an upregulated gene in ovarian cancer, and reported that the upregulation of LSD1 was associated...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8511

    authors: Shao G,Wan X,Lai W,Wu C,Jin J,Liu X,Wei Y,Lin Q,Zhang L,Shao Q

    更新日期:2018-06-01 00:00:00

  • A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant.

    abstract::In the present study, a low molecular weight polysaccharide, ABP-AW1, isolated from Agaricus blazei Murill was assessed for its potential adjuvant activity. ABP-AW1 is considered to create a 'depot' of antigen at a subcutaneous injection site. ICR mice were immunized with 100 μg ovalbumin (OVA) alone or with 100 μg OV...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2013.1484

    authors: Cui L,Sun Y,Xu H,Xu H,Cong H,Liu J

    更新日期:2013-10-01 00:00:00

  • BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer.

    abstract::Breast cancer 1 (BRCA1) and insulin-like growth factor 1 receptor (IGF1R) are critical in ovarian cancer progression. However, the crosstalk between the BRCA1 and IGF1R signaling pathways in ovarian cancer remains largely unknown. The effects of BRCA1 on IGF1R were assessed in 121 serous ovarian cancer patients (BRCA1...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.1929

    authors: Liu B,Li D,Guan YF

    更新日期:2014-05-01 00:00:00

  • The importance of Src signaling in sarcoma.

    abstract::Src is a tyrosine kinase that is of significance in tumor biology. The present review focuses on Src, its molecular structure, and role in cancer, in addition to its expression and function in sarcoma. In addition, the feasibility of Src as a potential drug target for the treatment of sarcoma is also discussed. Previo...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3184

    authors: Chen Q,Zhou Z,Shan L,Zeng H,Hua Y,Cai Z

    更新日期:2015-07-01 00:00:00

  • Promoter hypermethylation and downregulation of trefoil factor 2 in human gastric cancer.

    abstract::Trefoil factor 2 (TFF2) plays a protective role in gastric mucosa and may be involved in the progression of gastric cancer, but the detailed functions and underlying molecular mechanisms are not clear. The present study used a combination of clinical observations and molecular methods to investigate the correlation be...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.1904

    authors: Jiang P,Yu G,Zhang Y,Xiang Y,Zhu Z,Feng W,Lee W,Zhang Y

    更新日期:2014-05-01 00:00:00

  • Erratum: Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.

    abstract::[This corrects the article DOI: 10.3892/ol.2017.6254.]. ...

    journal_title:Oncology letters

    pub_type: 杂志文章,已发布勘误

    doi:10.3892/ol.2017.6794

    authors: Sato S,Kato T,Abe K,Hanaoka T,Yano Y,Kurosaki A,Yasuda M,Sekino T,Fujiwara K,Hasegawa K

    更新日期:2017-10-01 00:00:00

  • Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP-9 signaling pathways in human bladder cancer cells.

    abstract::Salidroside has a wide range of pharmacological activities, including antitumor, anti-inflammatory, analgesic, antibacterial, antiviral and anti-fertility abilities. In the present study, the effects of salidroside on the viability and apoptosis of bladder cancer cells, and the potential underlying mechanisms, were ex...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8982

    authors: Li T,Xu K,Liu Y

    更新日期:2018-09-01 00:00:00

  • Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer.

    abstract::Patients diagnosed preoperatively with ductal carcinoma in situ (DCIS) breast cancer have the potential to develop invasive ductal carcinoma (IDC). The present study investigated the usefulness of exosome-encapsulated microRNA-223-3p (miR-223-3p) as a biomarker for detecting IDC in patients initially diagnosed with DC...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8457

    authors: Yoshikawa M,Iinuma H,Umemoto Y,Yanagisawa T,Matsumoto A,Jinno H

    更新日期:2018-06-01 00:00:00

  • Inhibitory effect of MyoD on the proliferation of breast cancer cells.

    abstract::Skeletal muscle is rich in lymphatic vessels, with an abundant blood supply, and it is an infrequent site of cancer metastasis. Previous studies have demonstrated that enhanced secretion of MyoD may occur when skeletal muscle is injured or becomes cancerous. It was hypothesized that MyoD may act as an endogenous cytok...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4448

    authors: Cai C,Qin X,Wu Z,Shen Q,Yang W,Zhang S,Duan J,Liang F,Liu C

    更新日期:2016-06-01 00:00:00

  • Intracranial solitary fibrous tumors: A report of two cases and a review of the literature.

    abstract::Solitary fibrous tumors (SFTs) are uncommon, with the pleura as a site of predilection. Central nervous system SFTs, particularly intracranial SFTs, are extremely rare. The lesions are generally benign and localized, and surgery is the main therapeutic solution. The current study reports the cases of a patient who pre...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2015.3985

    authors: Wang ZY,Qiu K,Ma YH,Wang XT,Bao JJ,Zhang ZF,Liu XZ

    更新日期:2016-02-01 00:00:00

  • IL-32 promotes breast cancer cell growth and invasiveness.

    abstract::Interleukin (IL)-32 is a newly identified cytokine in humans and primates. It has been established that IL-32 may antagonize cancer growth. However, to the best of our knowledge, the direct effect of IL-32 on breast cancer cell growth has not yet been investigated. In addition, rodents lack the expression of IL-32; he...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2014.2641

    authors: Wang S,Chen F,Tang L

    更新日期:2015-01-01 00:00:00

  • Anti-Condyloma acuminata mechanism of microRNAs-375 modulates HPV in cervical cancer cells via the UBE3A and IGF-1R pathway.

    abstract::The present study aimed to identify the probable anti-Condyloma acuminata (CA) mechanism of microRNA-375 (miRNA-375) in human papillomavirus (HPV). Firstly, the overexpression of miRNA-375 significantly suppressed cell proliferation, increased lactate dehydrogenase activity and induced apoptosis in HPV-18(+) cervical ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8983

    authors: Wu S,Chen H

    更新日期:2018-09-01 00:00:00

  • CD44 promotes cell proliferation in non-small cell lung cancer.

    abstract::Cluster of differentiation 44 (CD44), a marker for cancer stem cells, has been reported to be associated with poor prognosis in non-small cell lung cancer (NSCLC), but its involvement in tumor growth has not fully been elucidated. The present study explored the associations between CD44 expression and clinicopathologi...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8051

    authors: Hu B,Ma Y,Yang Y,Zhang L,Han H,Chen J

    更新日期:2018-04-01 00:00:00

  • Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis.

    abstract::Expression of claudin-6 (CLDN6) in the tissues of gastric cancer patients and its association with clinical pathology and prognosis were investigated. A retrospective analysis was performed on 213 gastric cancer patients diagnosed and surgically treated in the Central Hospital of Zibo from January 2010 to January 2013...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10129

    authors: Gao F,Li M,Xiang R,Zhou X,Zhu L,Zhai Y

    更新日期:2019-05-01 00:00:00

  • Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis.

    abstract::Bladder cancer (BC) is one of the most common urogenital malignancies. However, present studies of its multiple gene interaction and cellular pathways remain unable to accurately verify the genesis and the development of BC. The aim of the present study was to investigate the genetic signatures of BC and identify its ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.9002

    authors: Yan M,Jing X,Liu Y,Cui X

    更新日期:2018-09-01 00:00:00

  • Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.

    abstract::Enhancement of antibody-dependent cellular cytotoxicity (ADCC) with some modalities may be a promising approach to enhance the efficacy of therapeutic monoclonal antibodies (mAbs). It has previously been demonstrated that the removal of fucose from antibody oligosaccharides (defucosylation) leads to augmentation of AD...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.7556

    authors: Nakajima T,Okayama H,Ashizawa M,Noda M,Aoto K,Saito M,Monma T,Ohki S,Shibata M,Takenoshita S,Kono K

    更新日期:2018-02-01 00:00:00

  • Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy.

    abstract::Treatment of cancer often requires the use of adjuvant chemotherapy (ACT). In real clinical practice, numerous patients suffer from severe toxicity and reduced quality of life (QoL). Hence, there is a need to maintain QoL and to reduce therapy toxicity to comply with recommended chemotherapy (CT) regimens. The present...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10868

    authors: Kaidarova DR,Kopp MV,Pokrovsky VS,Dzhugashvili M,Akimzhanova ZM,Abdrakhmanov RZ,Babich EN,Bilan EV,Byakhov AV,Gurov SN,Koroleva IA,Mochalova AS,Povaga SS,Raigorodsky MV,Saifullin AS,Sanz E,Petrovskiy FI

    更新日期:2019-11-01 00:00:00

  • Neuroendocrine tumors of the gallbladder.

    abstract::A gallbladder neuroendocrine neoplasm (GB-NEN) is a unique heterogeneous neoplasm, originating from neuroendocrine cells and able to secrete peptides as its neurotransmitter. Among all the neuroendocrine tumors (NETs), the GB-NEN prevalence is 0.5%, which accounts for ~2.1% of all gallbladder tumors. The current study...

    journal_title:Oncology letters

    pub_type: 杂志文章,评审

    doi:10.3892/ol.2020.11461

    authors: Niu C,Wang S,Guan Q,Ren X,Ji B,Liu Y

    更新日期:2020-05-01 00:00:00

  • Port-site metastasis as a primary complication following retroperitoneal laparoscopic radical resection of renal pelvis carcinoma or nephron-sparing surgery: A report of three cases and review of the literature.

    abstract::The present study reports the clinical data of two patients with renal pelvis carcinoma and one patient with renal carcinoma who developed port-site metastasis following retroperitoneal laparoscopic surgery. The current study aimed to identify the cause and prognosis of the occurrence of port-site metastasis subsequen...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.4541

    authors: Wang N,Wang K,Zhong D,Liu X,Sun JI,Lin L,Ge L,Yang BO

    更新日期:2016-06-01 00:00:00

  • Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.

    abstract::Nasopharyngeal carcinoma (NPC) is a common type of cancer worldwide. Long non-coding RNAs (lncRNAs) have been demonstrated to be associated with the development of multiple types of human cancer. The present study aimed to identify the potential role of lncRNA colon cancer associated transcript 1 (CCAT1) in NPC. Rever...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8969

    authors: Dong Y,Yuan H,Jin G

    更新日期:2018-08-01 00:00:00

  • Effect of IL-17 in the development of colon cancer in mice.

    abstract::Cytokine therapy is commonly used for tumor immunotherapy. Although early studies focused directly on the tumor, current investigations are more attentive of the tumor microenvironment. Various immune cells and related cytokines in the tumor microenvironment play an important role in the occurrence and development of ...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2016.5329

    authors: Yang L,Liu H,Zhang L,Hu J,Chen H,Wang L,Yin X,Li Q,Qi Y

    更新日期:2016-12-01 00:00:00

  • Comparison of diagnostic value of multi-slice spiral CT and MRI for different pathological stages of prostate cancer.

    abstract::Diagnostic value of magnetic resonance imaging (MRI) and multi-slice spiral CT (MSCT) for different pathological stages of prostate cancer was compared. A total of 112 patients with prostate cancer who underwent surgical pathology in The Affiliated Yantai Yuhuangding Hospital of Qingdao University from February 2014 t...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.10272

    authors: Sui Y,Li J,Zou Z,Shi Y,Hao C

    更新日期:2019-06-01 00:00:00

  • Reduced expression of microRNA-139-5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA-139-5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta-analysis and bi

    abstract::Hepatocellular carcinoma (HCC) is generally considered one of the most common gastrointestinal malignant tumors, characterized by high invasiveness and metastatic rate, as well as insidious onset. A relationship between carcinogenicity and aberrant microRNA-139-5p (miR-139-5p) expression has been identified in multipl...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2019.11031

    authors: Qin H,Wen DY,Que Q,Zhou CY,Wang XD,Peng YT,He Y,Yang H,Liao BM

    更新日期:2019-12-01 00:00:00

  • Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.

    abstract::Transcriptional co-activator with PDZ-binding motif (TAZ) is a transcriptional co-activator which binds to a variety of transcription factors. An increasing number of studies have provided evidence that TAZ may be a positive regulator of cell proliferation and tumorigenesis. To reveal the underlying mechanisms by whic...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2017.6030

    authors: Yang L,Huang M,Tan J,Hou J,He J,Wang F,Cui H,Yi L

    更新日期:2017-06-01 00:00:00

  • miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells.

    abstract::Although previous studies have demonstrated that dysregulation of microRNA (miR)-126 is associated with the progression of several types of cancer, including lung cancer, the relationship between miR-126 and lung cancer metastasis remains unclear. SPC-A1 lung cancer cells were transfected with miR-126 mimic and negati...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2018.8207

    authors: Jia Z,Zhang Y,Xu Q,Guo W,Guo A

    更新日期:2018-05-01 00:00:00

  • Study of the correlation between H-ras mutation and primary hepatocellular carcinoma.

    abstract::The aim of this study was to investigate the correlation between H-ras mutation and primary hepatocellular carcinoma (HCC) and to describe the role of H-ras mutation in carcinogenesis. Clinical samples of 69 patients were collected and the expression levels of H-ras in HCC and the surrounding normal tissues were exami...

    journal_title:Oncology letters

    pub_type: 杂志文章

    doi:10.3892/ol.2012.832

    authors: Sui G,Ma X,Liu S,Niu H,Dong Q

    更新日期:2012-10-01 00:00:00